Home 5 Lab Compliance Advisor 5 CLIA-lca 5 G2 Compliance Perspectives: Clinical Laboratories Face Expanded Exposure To False Claims and Overpayment Demands

G2 Compliance Perspectives: Clinical Laboratories Face Expanded Exposure To False Claims and Overpayment Demands

by | Feb 23, 2015

RRecently, amendments to the Medicare statute, evolving False Claims Act (FCA) jurisprudence, and subtle changes in Medicare regulatory requirements and interpretations have expanded the potential for exposure of clinical laboratories and other providers to false claims and allegations and overpayment demands. These changes alone warrant greater attention to regulatory compliance, but there is also a […]

RRecently, amendments to the Medicare statute, evolving False Claims Act (FCA) jurisprudence, and subtle changes in Medicare regulatory requirements and interpretations have expanded the potential for exposure of clinical laboratories and other providers to false claims and allegations and overpayment demands. These changes alone warrant greater attention to regulatory compliance, but there is also a […]

This content is Exclusive to Lab Compliance Advisor Subscribers

Subscribe or Log in for Exclusive Access.